Discover the ICAN IHU sponsors
Donations are essential to accelerate research.
Thank you to our sponsors for their loyal commitment!
Exceptional sponsors
Major sponsors
Constance and Andreï Rhoe Foundation
Major sponsors
Benefactors
MSDAVENIR
Dr Golriz PAHLAVAN – Chairman of the Scientific Advisory Board
“With a budget of 1.2 million euros, MSDAVENIR – France’s leading fund for supporting research in the life sciences – has decided to provide major support for the ICONIC project led by the ICAN IHU, in association with Inserm. This combination of cardiac and liver imaging and epidemiology will produce unique population data including young adults: a world first! Since 2015, MSD’s ambition has been to create synergies between the public and private sectors and to support researchers to encourage the emergence of innovations to benefit patients. ICONIC is a perfect illustration of MSD’s desire to support the most innovative research projects, to build the medicine of tomorrow and showcase the excellence of French research.”
Bouygues Group
Pierre AUBERGER – Central Communications Director, Bouygues Group
“As a patron of the arts, Bouygues is delighted to support the PEGASE project, launched by the ICAN IHU and led by cardiac surgeon Guillaume Lebreton, whose aim is to increase the number of heart transplants thanks to an ex-vivo perfusion device that preserves the heart until transplantation. Bouygues’ donation in 2023 made it possible to launch this project with a first heart transplant in January 2024 at the Pitié-Salpêtrière Hospital, which went well, opening up other prospects linked to the prolonged preservation of vital organs.”
BIOTRONIK
Emmanuel MARTINS – Regional Sales Director IDF / Normandy
” BIOTRONIK , a family-owned European company, was founded by two students at Berlin University. More than 50 years later, BIOTRONIK is one of the world’s leading companies in the field of medical devices. With the aim of perfectly uniting technology with the human body, BIOTRONIK innovations provide care that saves and improves the lives of millions of people with heart and blood vessel diseases every year. Passionate about education, BIOTRONIK understands the importance of supporting university medical projects. That’ s why it has been supporting the ICAN Foundation for several years now
Sicame Endowment Fund
Nadine VALET – Vice-President Sicame Group
“Medical research very quickly became an obvious choice for the Sicame Endowment Fund. We had to make our contribution, even if it was modest compared with the scale of the research programmes. We see this as an opportunity to provide experts and researchers with the technological and scientific resources they need to bring about advances in health that will benefit us all. Our meeting with the men and women of the IHU-ICAN was inspiring and reinforced our commitment to sponsorship. It’s all about being those invisible people who support medical research over the long term
Le Triomphe du Coeur Endowment Fund
Virginie NAHRA – President
“Le Triomphe du Coeur was founded in 2021 as a tribute to my husband, who was taken from us far too soon by sudden adult death caused by hypertrophic cardiomyopathy—an inherited heart condition that is often asymptomatic but fatal without early diagnosis. His passing strengthened my conviction that medical research is essential to preventing such tragedies and saving lives. That is why we support the OPTIM project, led by Prof. Philippe Charron at the IHU ICAN. This program aims to improve the screening and management of genetic heart diseases in order to anticipate risks and prevent further tragedies. Through donations and sponsorship, Le Triomphe du Coeur is actively committed to advancing this research. We are convinced that every scientific advance helps protect future generations and prevent other families from experiencing this same pain.”
Crédit Mutuel Alliance Fédérale
Daniel BAAL – President
“The Crédit Mutuel Alliance Fédérale Foundation supports numerous projects aimed at studying the impacts of the environment on health. This is one of its priority areas for philanthropy. It is currently estimated that more than 20% of chronic diseases are linked to environmental factors. Medical research is a major issue for public health, and yet it is clear that it is sorely lacking in funding. France has always been a key player in scientific research on the global stage: internationally recognized excellence driven by renowned institutions. It is our responsibility to stand with the scientific community by supporting projects such as the one led by the IHU ICAN teams, which aims to understand the impact of endocrine disruptors on metabolic liver disease. New technologies enable non-invasive diagnostics, improving comfort for affected patients. Supporting the purchase of state-of-the-art equipment means investing in the future of healthcare and is one of the most effective ways to accelerate progress.”
